Bipolar Disorder Journal Articles

• Cannabinoid-based Medications for Pain The popularity of cannabinoid-based medications for treating chronic pain is growing, but the interest in their use may be outpacing the evidence supporting their analgesic benefits
  Current Psychiatry, July 15, 2021
• Lifestyle and Comorbidities in Patients With Migraine This study aimed to compare the prevalence of unhealthy lifestyle factors and comorbid diseases between patients with migraine and migraine-free controls.
  Headache, July 05, 2021
• Neurogranin as a Novel Biomarker in Alzheimer's Disease This study evaluated the diagnostic value of CSF neurogranin and alpha-synuclein as biomarkers of synapsis damage in patients with Alzheimer disease.
  Laboratory Medicine, April 26, 2021
• A Review of Multimodal Hallucinations Review current thought on multimodal hallucinations--hallucinatory experiences which occur in multiple sensory systems. How prevalent are they, and what are their clinical implications?
  Schizophrenia Bulletin, April 16, 2021
• Brief Psychotic Disorder During COVID-19 Pandemic Might the intense psychosocial stress associated with a novel, potentially fatal disease along with lockdown restrictions be a trigger for first-episode psychosis?
  Schizophrenia Bulletin, March 16, 2021
• Pediatric Psoriasis Comorbidities This case presentation highlights the many comorbidities that can manifest in children with psoriasis, including juvenile psoriatic arthritis, uveitis, and metabolic disorders.
  Skin Therapy Letter, February 16, 2021
• Chronic Disease Among African American Families This review summarizes research examining chronic conditions among multiple members of African American families with the aim of increasing understanding of the burden caused family comorbidity.
  Preventing Chronic Disease, January 19, 2021
• Hallucinations in Older Adults: A Practical Review This review highlights key issues for the clinician caring for older adults with hallucinations. How is assessment, management, and treatment best approached?
  Schizophrenia Bulletin, January 15, 2021
• Metabolism of Sphingolipids in the Brain of Schizophrenics Might altered sphingolipid metabolism be a factor in the structural and molecular abnormalities of white matter reported in schizophrenia?
  Schizophrenia Bulletin, December 16, 2020
• Polypharmacy and Potential Drug-Drug Interactions for HIV Are you aware of the types of concurrent medications commonly prescribed to HIV patients and the potential drug-drug interactions?
  HIV Medicine, October 09, 2020
• Deprescribing Guidance for Hydroxychloroquine Drug Interactions This study assessed the burden of potentially inappropriate medications that could be deprescribed if necessary to initiate treatment with hydroxychloroquine or other potential COVID-19 therapies.
  Journal of the American Geriatrics Society, September 07, 2020
• Effect of Increased Levothyroxine Dose on Depressive Mood Increased doses of levothyroxine may help improve depressive symptoms among older hypothyroid patients receiving hormone replacement therapy.
  Clinical Endocrinology, September 01, 2020
• Developments in Diagnosis and Treatment of People With BPD Get up-to-date on the most recent developments in diagnostic and treatment approaches for borderline personality disorder.
  Current Opinion in Psychiatry, August 24, 2020
• Neurofilaments: Neurobiological Foundations for Biomarkers Learn about the role of neurofilaments in the pathogenesis of disease. How might neurofilament peptide concentrations be potentially useful as biomarkers of neuronal injury or degeneration?
  Brain, August 12, 2020
• Implementing Office-Based Opioid Treatment in Primary Care How has medication-assisted treatment for opioid use disorder been successfully integrated into primary care clinics? This report details the experience across one U.S. state.
  Journal of the American Board of Family Medicine, August 05, 2020
• Managing Treatment-Resistant Depression Nearly 25% of patients may have an inadequate response to depression therapy. Review the diagnosis and available therapeutic options for treatment-resistant depression in this article.
  U.S. Pharmacist, July 28, 2020
• Ketamine for Chronic Pain: Old Drug New Trick? This commentary highlights the many uses of ketamine in the practice of anesthesia as well as psychiatry. What place might it have in our chronic pain treatment arsenal?
  Anesthesiology, July 02, 2020
• Transition of Substance-Induced Psychoses to Schizophrenia What proportion of people with substance-induced psychoses transition to schizophrenia? What might be potential moderators for risk?
  Schizophrenia Bulletin, May 20, 2020
• Potential Clinical Role for Exome Sequencing in Schizophrenia This study assessed the value of exome sequencing to screen for disruptive and damaging variants which might play a role in schizophrenia.
  Schizophrenia Bulletin, April 20, 2020
• Gabapentin for the Treatment of Hot Flushes in Menopause Is gabapentin a useful alternative to hormonal therapies for the treatment of vasomotor symptoms in postmenopausal women?
  Menopause, April 14, 2020